|
SGMS2 expression based on
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.146100E-02 |
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 4 samples. One sample from American Indian patient is not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.578200E-02 |
| Normal-vs-AfricanAmerican |
3.883800E-01 |
| Normal-vs-Asian |
1.309970E-01 |
| Caucasian-vs-AfricanAmerican |
2.852100E-02 |
| Caucasian-vs-Asian |
7.938600E-01 |
| AfricanAmerican-vs-Asian |
4.306800E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.924150E-01 |
| Normal-vs-Female |
1.386080E-02 |
| Male-vs-Female |
1.355220E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Four samples from patients aged below 21 are not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.131970E-01 |
| Normal-vs-Age(41-60Yrs) |
1.064820E-01 |
| Normal-vs-Age(61-80Yrs) |
1.480170E-02 |
| Normal-vs-Age(81-100Yrs) |
4.784800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.876800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.354200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.738000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.327600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.820800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.192800E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Paraganglioma |
1.771230E-01 |
| Normal-vs-Pheochromocytoma |
7.854300E-02 |
| Normal-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
1.305850E-02 |
| Paraganglioma-vs-Pheochromocytoma |
7.474000E-01 |
| Paraganglioma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
3.221200E-01 |
| Pheochromocytoma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
2.201600E-01 |
|
|
